Back

Heart failure therapy in new onset heart failure versus chronic heart failure: an analysis of 90,383 patients from the Swedish Heart Failure Registry (SwedeHF)

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Chronic heart failure treatment Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Angiza Shahim

Karolinska Institutet, Stockholm (Sweden)

4 More presentations in this session

Presentation thumbnail
Ultra-fast remote up-titration of heart failure treatment: a safe, efficient and feasible protocol
Doctor M. Massot (Toulouse, FR)
Abstract Slides
Presentation thumbnail
Increasing the class of foundational medication for heart failure is associated with improved prognosis in hospitalized patients with heart failure with reduced or mildly reduced ejection fraction
Doctor D. Maeda (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Effects of sodium glucose cotransporter 2 inhibitors on the risk of hyperkalemia in patients on mineralocorticoid receptor antagonist: a systematic review and meta-analysis
Doctor R. Cordovez (Cebu City, PH)
Abstract Slides
Presentation thumbnail
Effect of diuretic down-titration on pulmonary congestion assessed by lung ultrasound when introducing sodium-glucose cotransporter 2 inhibitors
Doctor M. Domingo (Badalona, ES)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure treatment

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?
thumbnail
Congress Presentation
Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion
thumbnail
Congress Presentation
Expert panel discussion and Q&A

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources